EMEA-003199-PIP01-22 - paediatric investigation plan

224 Radium adsorbed in calcium carbonate microparticles

Key facts

• Active substance:
  224 Radium adsorbed in calcium carbonate microparticles
• Therapeutic area:
  Oncology
• Decision number:
  P/0252/2022
• PIP number:
  EMEA-003199-PIP01-22
• Pharmaceutical form(s):
  Suspension for injection
• Condition(s) / indication(s):
  Treatment of peritoneal carcinomatosis
• Route(s) of administration:
  Intraperitoneal use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  08/07/2022
• Compliance check done:
  No

Decision

P/0252/2022 : EMA decision of 8 July 2022 on the granting of a product specific waiver for 224Radium adsorbed in calcium carbonate microparticles (EMEA-003199-PIP01-22)

Reference Number: EMA/579377/2022